WO1998040063A1 - Quaternary salts of 2-hydroxy acids - Google Patents

Quaternary salts of 2-hydroxy acids Download PDF

Info

Publication number
WO1998040063A1
WO1998040063A1 PCT/US1998/004969 US9804969W WO9840063A1 WO 1998040063 A1 WO1998040063 A1 WO 1998040063A1 US 9804969 W US9804969 W US 9804969W WO 9840063 A1 WO9840063 A1 WO 9840063A1
Authority
WO
WIPO (PCT)
Prior art keywords
salt
acid
quaternary
triethanolamine
diethanolamine
Prior art date
Application number
PCT/US1998/004969
Other languages
French (fr)
Original Assignee
Jame Fine Chemicals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jame Fine Chemicals, Inc. filed Critical Jame Fine Chemicals, Inc.
Publication of WO1998040063A1 publication Critical patent/WO1998040063A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/06Glycolic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Abstract

Quaternary salts of 2-hydroxy acids with an alkanolamine such as monoethanolamine, diethanolamine or triethanolamine are useful for incorporation in skin and cosmetic formulations. The acid may contain 2 to 24 carbon atoms, preferably 2 to 17 carbon atoms. The monoethanolamine, diethanolamine and triethanolamine salts of 2-hydroxy acids such as glycolic, lactic, 2-hydroxydecanoic, 2-hydroxyoctanoic and 2-hydroxylauric acid are quite water-soluble and cosmetic formulations containing such salts are non-irritating to the skin.

Description

QUATERNARY SALTS OF 2-HYDROXY ACIDS
Background of the Invention
Alpha-hydroxy acids (i.e. 2-hydroxy acids) are known in the prior art. Such acids are used extensively in cosmetic formulations. However, there are a number of disadvantages associated with the use of such acids in cosmetic formulations. In particular, such acids are generally insoluble in water or other non-toxic solvents. Moreover, these acids can be highly corrosive effect to the skin.
Objects of the Invention
It is an object of the invention to provide 2-hydroxy acid compositions which will be highly soluble in water and other non-toxic solvents commonly used in cosmetic formulations (e.g. 1,3-butylene glycol).
It is a further object of the invention to provide 2-hydroxy acid compositions which will be less irritating to the skin than prior art 2-hydroxy acids when incorporated into cosmetic formulations.
Details of the Invention The objects of the invention have been met by providing novel quaternary salts of 2-hydroxy acids. Such salts will be the quaternary salts of the 2-hydroxy acids with an alkanolamine which may be monoethanolamine, diethanolamine or triethanolamine .
The quaternary salts of the 2-hydroxy acids will have a formula selected from the group consisting of:
+ R-CH( OH ) -COO- NH3CH2CH2OH
+ R-CH ( OH ) -COO- NH2 ( CH2CH2OH ) 2 and
+ R-CH ( OH ) -COO- NH( CH2CH2OH ) 3
wherein R is hydrogen or a Cj-C22 , preferably C3-C15 , alkyl group . The 2-hydroxy acid will generally be one which has 2 to about 24, preferably 2 to 17, carbon atoms. Preferable examples of such 2-hydroxy acids include glycolic acid, lactic acid, 2-hydroxydecanoic acid, 2-hydroxyoctanoic acid and 2-hydroxylauric acid.
The 2-hydroxy acid quaternary salts of the invention may be readily prepared as follows:
(a) dissolve the selected 2-hydroxy acid in a non-reactive solvent; (b) add an alkanolamine selected from the group consisting of monoethanolamine, diethanolamine and triethanolamine to the solution resulting from step (a); and (c) recover the quaternary salt from the reaction mixture resulting from step (b) or utilize the quaternary salt in the form of a solution without recovery thereof.
In step (a), the choice of solvent is not critical so long as it is one which is non-reactive with the selected 2-hydroxy acid or the selected alkanolamine. Thus the solvent may be non-polar in nature such as methylene chloride, ethyl acetate, n-hexane, n-heptane and the like; alternatively, the solvent may be polar in nature such as water or a non-toxic solvent such as isopropanol, 1,3-butylene glycol, isocetyl alcohol, etc. Preferably, the non-reactive solvent is non- polar in nature such as methylene chloride. Typically, 15 to 30 parts by weight of the selected 2-hydroxy acid will be utilized per 100 parts by weight of the selected non-polar solvent. Step (a) is conveniently carried out at temperatures of about 15 to 50°C.
In step (b), the selected alkanolamine is added, with stirring, to the solution of the 2-hydroxy acid. Generally, the alkanolamine will be utilized in an amount corresponding to the stoichiometric amount required for the selected 2-hydroxγ acid. Step (b) is also conveniently carried out at temperatures of about 15 to 50°C. The reaction between the 2-hydroxy acid and the alkanolamine proceeds fairly quickly and is exothermic in nature. Therefore, cooling the reaction mixture to a temperature of about 25 to 35 °C and adding the alkanolamine slowly, e.g. over a period of time of about 0.5 to 1 hour, is desirable.
In step (c), the quaternary salt will precipitate out if the selected solvent was non-polar in nature and is readily recovered by filtration. Typically, the salt will be washed with non-polar solvents such as methylene chloride and/or n-heptane to remove any unreacted components and thereafter dried (in air and/or vacuum-dried at temperatures of about 40 to 70°C). Alternatively, if the selected solvent was a non- toxic polar solvent and it is desired to manufacture a solvent solution of the quaternary salt, the salt need not be recovered from the reaction mixture.
Typically, the yield of the quaternary salt will be nearly quantitative, e.g. 80-98% of theory. The quaternary salts of the 2-hydroxy acids of the invention will typically have a water solubility of about 15 to 30 wt.%.
The following examples shall serve to illustrate the invention. Unless otherwise indicated, all parts and percentages are on a weight basis.
Example 1
A 3-liter, 3-neck flask was equipped with a stirrer, thermometer, condenser, addition funnel and a heating/cooling bath. 282 g (1.5 m) of 2-hydroxydecanoic acid were placed in the flask together with 1.5 kg of methylene chloride. Stirring was commenced and the temperature was adjusted to 30°C. 223.8 g (1.5 m) of triethanolamine was added, while stirring the reaction mixture, over a period of 1 hour, while the temperature of the reaction mixture was maintained in the range of 27 to 33°C by external cooling.
The reaction mixture was stirred for an additional two hours, while maintaining the temperature at 35 °C. The reaction mixture was then cooled to 20"C and the precipitate was collected by filtration. The product (i.e. the precipitate) was washed with 500 g methylene chloride and thereafter washed with 300 g of n-heptane. The product was air-dried for several hours and thereafter dried under vacuum at 50- 60"C for 4 hours. The product yield was 481 g (95% of theory). The product was soluble in water in excess of 20 wt.%.
Example 2 Example 1 was repeated using 188 g (1.0 m) of 2-hydroxy- decanoic acid, 940 g methylene chloride and 105 g (1.0 m) of diethanolamine. After working up the product in the same manner, 273 g of product (93.2% of theory) was obtained. The product was soluble in water in excess of 20 wt.%.
Example 3
Example 1 was repeated using 160 g (1.0 m) 2-hydroxyoctanoic acid, 1.0 kg methylene chloride and 149.2 g (1.0 ) of triethanolamine. After working up the product in the same manner, 290 g of product (94% of theory) was obtained. The product was soluble in water in excess of 20 wt.%.
Example 4
Example 3 was repeated using 105 g (1.0 m) of diethanolamine instead of the triethanolamine. 236 g (89% of theory) of product was obtained. The product was soluble in water in excess of 20 wt.%.
Example 5
Example 1 was repeated using a 1-liter, 3-neck flask. 25.33 g (0.33 m) of glycolic acid was dissolved in 200 ml ethyl acetate at a temperature of 35-45 °C. Thereafter, 49.7 g (0.33 m) of triethanolamine was added over a period of one hour and stirring was continued for 2 hours at 40°C. 69 g (92% of theory) of product having a solubility in water in excess of 20 wt.% were obtained. Example 6
Example 1 was repeated using 212 g (1.0 m) of 2-hydroxylauric acid, 1.5 kg methylene chloride and 149.2 g (1.0 m) triethanolamine). 346 g (95.8% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 7
Example 6 was repeated using 105 g (1.0 m) of diethanolamine instead of the triethanolamine. 346 g (95.8% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 8
Example 1 was repeated using a 1-liter, 3-neck flask. 29.5 g of 85% d-1 lactic acid (0.28 m) was dissolved in 150 g of isopropanol at a temperature of 35-45 °C. Thereafter, 41.7 g (0.28 m) of triethanolamine was added over a period of one hour and stirring was continued for 2 hours at 35 βC. The reaction mixture was cooled to 5°C and the product was filtered and washed with isopropanol and thereafter vacuum-dried. 56 g (84% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 9
Example 3 was repeated using 100 g (0.625 m) 2-hydroxγ- octanoic acid, 550 g methylene chloride and 38.2 g (0.625 m) of monoethanolamine. After working up the product in the same manner, 121 g of product (87.6% of theory) was obtained. The product was soluble in water in excess of 20 wt.%.

Claims

WHAT IS CLAIMED IS:
1. A quaternary salt of a 2-hydroxy acid having the formula selected from the group consisting of:
+ R-CH(OH)-COO- NH 3,C«--Hπ2,Cι_Hr-,2O.H
R-CH(OH)-COO- NH 2,((CCHHCCHH,2O(_»Hπ) 2, and
+ R-CH(OH)-COO- NH(CH2CH2OH)3
wherein R is hydrogen or a C C22 alkyl group.
2. The salt of claim 1 wherein R is hydrogen.
3. The salt of claim 1 wherein R is a C3-C15 alkyl group.
4. The salt of claim 1 wherein the 2-hydroxy acid is selected from the group consisting of glycolic acid, lactic acid, 2-hydroxydecanoic acid, 2-h╬│droxyoctanoic acid and 2-hydroxylauric acid, and the alkanolamine is selected from the group consisting of monoethanolamine, diethanolamine and triethanolamine.
5. The salt of claim 1 comprising the quaternary salt of glycolic acid with monoethanolamine.
6. The salt of claim 1 comprising the quaternary salt of glycolic acid with diethanolamine.
7. The salt of claim 1 comprising the quaternary salt of glycolic acid with triethanolamine.
8. The salt of claim 1 comprising the quaternary salt of lactic acid with monoethanolamine.
9. The salt of claim 1 comprising the quaternary salt of lactic acid with diethanolamine.
10. The salt of claim 1 comprising the quaternary salt of lactic acid with triethanolamine.
11. The salt of claim 1 comprising the quaternary salt of 2-h╬│droxydecanoic acid with monoethanolamine.
12. The salt of claim 1 comprising the quaternary salt of 2-hydroxydecanoic acid with diethanolamine.
13. The salt of claim 1 comprising the quaternary salt of 2-hydroxydecanoic acid with triethanolamine.
14. The salt of claim 1 comprising the quaternary salt of 2-hydroxyoctanoic acid with monoethanolamine.
15. The salt of claim 1 comprising the quaternary salt of 2-hydroxyoctanoic acid with diethanolamine.
16. The salt of claim 1 comprising the quaternary salt of 2-hydroxyoctanoic acid with triethanolamine.
17. The salt of claim 1 comprising the quaternary salt of 2-hydroxylauric acid with monoethanolamine.
18. The salt of claim 1 comprising the quaternary salt of 2-hydroxylauric acid with diethanolamine.
19. The salt of claim 1 comprising the quaternary salt of 2-hydroxylauric acid with triethanolamine.
PCT/US1998/004969 1997-03-14 1998-03-13 Quaternary salts of 2-hydroxy acids WO1998040063A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81876697A 1997-03-14 1997-03-14
US08/818,766 1997-03-14

Publications (1)

Publication Number Publication Date
WO1998040063A1 true WO1998040063A1 (en) 1998-09-17

Family

ID=25226348

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/004969 WO1998040063A1 (en) 1997-03-14 1998-03-13 Quaternary salts of 2-hydroxy acids

Country Status (1)

Country Link
WO (1) WO1998040063A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1219288A2 (en) * 2000-12-21 2002-07-03 Johnson & Johnson Consumer Companies, Inc. Treatment for skin
GB2372743A (en) * 2000-12-20 2002-09-04 Teklube Ltd Non-toxic bioresistant lactic acid amides and preparation thereof
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
GB2372743A (en) * 2000-12-20 2002-09-04 Teklube Ltd Non-toxic bioresistant lactic acid amides and preparation thereof
GB2372743B (en) * 2000-12-20 2004-03-10 Teklube Ltd Aqueous metal-working fluid containing a lactamide, and process for producing alactamide for use in such fluid
EP1219288A2 (en) * 2000-12-21 2002-07-03 Johnson & Johnson Consumer Companies, Inc. Treatment for skin
EP1219288A3 (en) * 2000-12-21 2003-07-30 Johnson & Johnson Consumer Companies, Inc. Treatment for skin

Similar Documents

Publication Publication Date Title
TW336226B (en) Use of not easily volatilised pyrazol derivatives with hydrophilic groups as nitrification inhibitors
IE46471B1 (en) Novel oxime derivatives and their preparation
JPH10226674A (en) Quasi-ceramide compound, its production and cosmetic composition containing the same
JP3522817B2 (en) Taurine derivative, method for producing the same, detergent composition containing the compound, and intermediate thereof
WO1998040063A1 (en) Quaternary salts of 2-hydroxy acids
EP0331556A2 (en) Process for the preparation of ethylene diamine N,N'-bis(ortho-hydroxyphenylacetic) acid and derivatives thereof
US3953605A (en) Antimicrobial quaternary ammonium compounds compositions
US3721693A (en) Metal halide-ester reaction process and compositions
KR100450007B1 (en) Aqueous Synthesis of Iodopropargyl Carbamate
JPS6222752A (en) Production of guazatine 3-alkylbenzenesulfonic acid salt
US2909535A (en) Novel higher aliphatic acid derivatives and compositions containing the same
US4059687A (en) Ester substituted dibiguanides and non-toxic antimicrobial compositions thereof
JP2714724B2 (en) Cyclic amine compounds having a carboxyl group
US3251875A (en) N-nitroso derivatives
GB1583363A (en) Amphoteric fluorinated sulphonamides
US2655532A (en) N-oxoalkyl-para-aminosalicylic acids
CA2162906A1 (en) Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
WO2006034175A1 (en) Synthesis process for 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid
US5981795A (en) Method for the N-denitration of N-nitro-dinitroaniline in a homogeneous phase
US3052683A (en) 4-phenyl-1-(2-phenylsulfinylethyl)-4-propionoxypiperidine and method for its preparation
JPH05508633A (en) Intermediates used in the preparation of deferoxamine
JP2613857B2 (en) Phosphobetaine
JP3503993B2 (en) Method for producing N-mono-t-butyloxycarbonylalkylenediamine
JP3066466B2 (en) Tris-tert-butoxy carbonate of trisphenol and composition containing the same
JP2939650B2 (en) New sugar derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP KR

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998539851

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase